Hannover, Germany

Gregor Schurmann

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Mind of Gregor Schurmann: A Leading Inventor in Biopharmaceuticals

Introduction: Gregor Schurmann is a distinguished inventor based in Hannover, Germany, known for his significant contributions to the field of biopharmaceuticals. With a prolific portfolio consisting of 12 patents, his innovative work focuses on peptide and peptidomimetic inhibitors, particularly targeting plasma kallikrein.

Latest Patents: Among his most recent inventions are the peptide and peptidomimetic inhibitors that provide novel approaches for inhibiting and/or antagonizing plasma kallikrein. These inventions not only showcase his inventive prowess but also offer methods for utilizing these inhibitors as therapeutics, highlighting their potential impact on medical treatments.

Career Highlights: Gregor has had a remarkable career, during which he has worked with renowned companies such as E.I. du Pont de Nemours and Company and Ra Pharmaceuticals, Inc. His experience in these influential organizations has helped him refine his skills and drive significant innovations in drug development and therapeutics.

Collaborations: Throughout his career, Gregor has collaborated with notable professionals in his field, including Eberhard Schneider and Peter Wagner. These collaborations have played a crucial role in advancing his research and expanding the scope of his inventions.

Conclusion: Gregor Schurmann stands out as an influential figure in the realm of inventors dedicated to advancing biopharmaceutical innovations. With his numerous patents and extensive collaboration with leading companies and professionals, he continues to contribute to the progress of therapeutics, paving the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…